Dr. Jatoi on SLN Biopsy in ER-Positive, HER2-Negative Breast Cancer
July 25th 2022Ismail Jatoi, MD, discusses the importance of individualized care when deciding whether to omit sentinel lymph node biopsy in patients over the age of 70 with clinically node-negative, estrogen receptor–positive, HER2-negative breast cancer.
Read More